2025-522513-30-00招募中1 期
A trial to learn how well different doses of andexanet alfa work and how they affect blood clotting throughout the body in healthy adults who have taken an FXa inhibitor
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 108
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
AstraZeneca Clinical Study Information Centre
Scientific
AstraZeneca AB
研究点 (1)
Loading locations...
相似试验
尚未招募
4 期
A Randomized Clinical Trial of Andexanet Alfa in acute intracranial haemorrhage in patients receiving an oral factor Xa inhibitorNL-OMON54049Alexion Pharmaceuticals, Inc.45
招募中
4 期
A phase 4 Randomized Clinical Trial of Andexanet Alfa [Andexanet Alfa for injection] in acute intracranial haemorrhage in patients receiving an oral factor Xa inhibitorNL-OMON49173Portola Pharmaceuticals Inc.12
已完成
4 期
A Phase 4 Randomized Clinical Trial of Andexanet Alfa [Andexanet Alfa for Injection] in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor Xa InhibitorIntracranial Hemorrhagebrain bleeding (e.g. subdural, subarachnoidal)DRKS00017102Alexion Pharmaceutical, Inc.550
尚未招募
3 期
Evaluation of the effect of low-dose naltrexone in patients with Trigeminal Neuralgia and Chronic migraine patientsTrigeminal neuralgiaCondition 1: Trigeminal Neuralgia. Condition 2: Chronic Migraine.Chronic migraine without auraG50.0G43.7IRCT20171109037332N2Kerman University of Medical Sciences40
进行中（未招募）
1 期
A phase 4 clinical trial to study the effect of andexanet alfa compared to the usual care with regards to stopping severe/life threatening bleeding in patients with bleeding inside the skull.Oral FXa inhibitor-treated patients with acute intracranial bleedingMedDRA version: 20.0Level: LLTClassification code 10075279Term: Anticoagulant reversal therapySystem Organ Class: 100000004865EUCTR2018-002620-17-ITPORTOLA PHARMACEUTICALS INC439